prescription drugs

Galderma CareConnect hits milestoneGalderma’s patient access program Galderma CareConnect recently passed the 1,000,000 filled prescriptions.
Three reasons for nonadherenceUncover the root causes of why patients become nonadherent and be better positioned to improve the lives of patients and reduce costs through improved health outcomes.
Top 3 things to know: GOP ACA replacement planRepublicans recently unveiled their ACA replacement plan. Here’s what the experts say you need to know.
Aggressive price growth pushes healthcare spending upRise in use of outpatient care and professional services contributed to quicker growth in spending for the privately insured over previous years.
HHS proposes clampdown on short-term health coverageHHS has announced steps aimed at limiting short-term health plans and strengthening the marketplaces. Here's how you will be affected.
Public opinion shifts about the ACAA new study explores the tangible effects of the ACA and the study author weighs in on the implications for managed care.
Brand-name patent losses raise pharma cost concernsA number of traditional brand-name pharmaceuticals have lost, or will lose, patent protection this year. What does this mean over the longer-term for controlling costs?
Anthem, Express Scripts battle over drug pricesIndustry insiders believe that the Anthem lawsuit against Express Scripts over drug pricing may provide some clues into this complex situation.
Do prescription drug monitoring programs work?
Do prescription drug monitoring programs work?An in-depth look at the effects of PDMPs, which are electronic databases used to track the prescribing and dispensing of controlled prescription drugs to patients.
More young white males dying from drug overdosesIt is young white males who are dying from drug overdoses in the U.S., according to a New York Times analysis of death certificates.